Khairul Najmi Muhammad Nawawi

A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer

Liyana Zaharuddin, Norfilza Mohd Mokhtar, Khairul Najmi Muhammad Nawawi et al. · BMC Gastroenterology · 2019 · 285 citations · Full text

Life Sciences, Microbiology, Oncology +16

The Effect of Probiotics (MCP® BCMC® Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non-Alcoholic Fatty Liver Disease

Mohamad Hizami Mohamad Nor, Nurainina Ayob, Norfilza Mohd Mokhtar et al. · Nutrients · 2021 · 168 citations · Full text

Life Sciences, Immunology, Microbiology +17

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 83 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease

Nurainina Ayob, Khairul Najmi Muhammad Nawawi, Mohamad Hizami Mohamad Nor et al. · Biomedicines · 2023 · 65 citations · Full text

Life Sciences, Microbiology, Nutritional Sciences +17

Probiotic containing <i>Lactobacillus reuteri DSM 17648</i> as an adjunct treatment for <i>Helicobacter pylori</i> infection: A randomized, double‐blind, placebo‐controlled trial

Nur Izreena Ismail, Khairul Najmi Muhammad Nawawi, Deborah Chew Chia Hsin et al. · Helicobacter · 2023 · 59 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13